| Literature DB >> 35875004 |
Bingbing Xiang1, Shulan Jiao2, Yongyu Si2, Yuting Yao3, Feng Yuan1, Rui Chen1.
Abstract
Background: Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and outcomes of postoperative pneumonia.Entities:
Keywords: outcomes; pathogen distribution; perioperative; postoperative pneumonia; risk factors
Mesh:
Year: 2022 PMID: 35875004 PMCID: PMC9304902 DOI: 10.3389/fpubh.2022.913897
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Distribution of postoperative pneumonia in each surgical specialty.
|
|
|
|
|
|---|---|---|---|
| Neurosurgery | 600 | 102 | 17.00% |
| Hepatobiliary | 2,305 | 52 | 2.26% |
| General and digestive | 1,300 | 35 | 2.69% |
| Thoracic | 300 | 26 | 8.67% |
| Urology | 2,624 | 16 | 0.61% |
| Obstetric | 1,450 | 8 | 0.55% |
| Traumatology | 542 | 6 | 1.11% |
| Gynecology | 593 | 4 | 0.67% |
| Cardiac and vascular | 218 | 5 | 2.29% |
| Burns | 357 | 4 | 1.12% |
| Ear–nose–throat (ENT) | 456 | 2 | 0.44% |
| Neurology | 367 | 2 | 0.54% |
| Orthopedic | 851 | 1 | 0.12% |
| Other | 2,227 | 0 | 0% |
Distribution and ratio of pathogens.
|
|
|
|
|---|---|---|
|
| 98 | 64.05 |
| Klebsiella pneumoniae | 34 | 22.22 |
| Escherichia coli | 18 | 11.76 |
| Acinetobacter baumannii | 13 | 8.50 |
| Pseudomonas aeruginosa | 8 | 5.23 |
| Stenotrophomonas maltophilia | 5 | 3.27 |
| Other enterobacteria | 20 | 13.07 |
|
| 42 | 27.45 |
| Staphylococcus aureus | 14 | 9.15 |
| Staphylococcus hemolyticus | 4 | 2.61 |
| Staphylococcus epidermidis | 5 | 3.27 |
| Streptococcus | 7 | 4.58 |
| Enterococcus | 12 | 7.84 |
|
| 13 | 8.50 |
| Candida albicans | 8 | 5.23 |
| Other candida | 5 | 3.27 |
Risk factors for POP—univariate analysis.
|
|
|
| |
|---|---|---|---|
| Age (yr) | 54.70 ± 14.85 | 48.73 ± 14.86 | <0.001 |
| Age grading | |||
| ≥60 yr | 102 (38.64%) | 59 (22.35%) | <0.001 |
| <60 yr | 162 (61.36%) | 205 (77.65%) | |
| Sex | |||
| Male | 155 (58.71%) | 132 (50.0%) | 0.044 |
| Female | 109 (41.29%) | 132 (50.0%) | |
| Weight (kg) | 61.12 ± 10.88 | 60.35 ± 10.25 | 0.408 |
| BMI | |||
| ≥24 kg/m2 | 103 (46.8%) | 92 (35.4%) | 0.011 |
| <24 kg/m2 | 117 (53.2%) | 168 (64.6%) | |
| ASA physical status | |||
| ≥ 3 | 143 (54.2%) | 106 (40.2%) | 0.001 |
| < 3 | 121 (45.8%) | 158 (59.8%) | |
| Coma (GCS < 8) | 34 (12.9%) | 5 (1.9%) | <0.001 |
| Smoking | 112 (42.4%) | 83 (31.4%) | 0.009 |
| Drinking | 91 (34.5%) | 66 (25.0%) | 0.017 |
| Hypertension | 81 (30.7%) | 52 (19.7%) | 0.004 |
| Diabetes | 28 (10.6%) | 14 (5.3%) | 0.024 |
| Malignancy | 86 (32.6%) | 52 (19.7%) | 0.001 |
| COPD | 33 (12.5%) | 6 (2.3%) | <0.001 |
| Coronary heart disease | 7 (2.7%) | 6 (2.3%) | 0.779 |
| Stroke | 15 (5.7%) | 8 (3.0%) | 0.136 |
| Liver disease | 7 (2.7%) | 10 (3.8%) | 0.460 |
| Renal dysfunction | 6 (2.3%) | 2 (0.8%) | 0.154 |
| Preoperative prophylactic antimicrobial use | 254 (96.2%) | 257 (97.3%) | 0.460 |
| Preoperative hemoglobin | |||
| < 100 g/L | 19 (7.2%) | 15 (5.7%) | 0.478 |
| ≥ 100 g/L | 245 (92.8%) | 249 (94.3%) | |
| Postoperative hemoglobin | |||
| < 100 g/L | 87 (33.0%) | 44 (16.7%) | <0.001 |
| ≥ 100 g/L | 177 (67.0%) | 220 (83.3%) | |
| Preoperative albumin | |||
| <35 g/L | 47 (17.8%) | 40 (15.2%) | 0.412 |
| ≥35 g/L | 217 (82.2%) | 224 (84.8%) | |
| Postoperative albumin | |||
| <35 g/L | 198 (75.0%) | 117 (44.3%) | <0.001 |
| ≥35 g/L | 66 (25.0%) | 147 (55.7%) | |
| Surgical difficulty classification criteria | |||
| ≥ 4 | 182 (68.9%) | 151 (57.2%) | 0.005 |
| <3 | 82 (31.1%) | 113 (42.8%) | |
| Duration of surgery (h) | 4.67 ± 3.20 | 3.40 ± 2.18 | <0.001 |
| ≥ 3 h | 178 (67.4%) | 132 (50.0%) | <0.001 |
| < 3 h | 86 (32.6%) | 132 (50.0%) | |
| Emergency surgery | 58 (22.1%) | 19 (7.2%) | <0.001 |
| Night operation | 66 (25.0%) | 12 (4.5%) | <0.001 |
| Intraoperative blood loss (ml) | 586.1 ± 1,428.0 | 243.2 ± 256.6 | <0.001 |
| ≥ 400 ml | 107 (40.5%) | 67 (25.4%) | <0.001 |
| <400 ml | 157 (59.5%) | 197 (74.6) | |
| Intraoperative RBC transfusion | 48 (18.2%) | 19 (7.2%) | <0.001 |
| Intraoperative albumin infusion | 16 (6.1%) | 21 (8.0%) | 0.394 |
| Amount of intraoperative liquid | |||
| ≥ 4,000 ml | 104 (39.4%) | 56 (21.2%) | <0.001 |
| <4,000 ml | 160 (60.6%) | 208 (78.8%) | |
| Radial artery cannulation | 239 (90.5%) | 233 (88.3%) | 0.396 |
| Deep vein catheterization | 196 (74.2%) | 148 (56.1%) | <0.001 |
| Gastric tube intubation | 84 (31.8%) | 52 (19.7%) | 0.001 |
| Duration of ventilation | |||
| ≥ 24 h | 81 (30.7%) | 16 (6.1%) | <0.001 |
| <24 h | 183 (69.3%) | 248 (93.9%) | |
| Duration of postoperative bed rest | |||
| ≥ 3 days | 177 (67.0%) | 86 (32.6%) | <0.001 |
| <3 days | 87 (33.0%) | 178 (67.4%) |
BMI, Body mass index; ASA, American Society of Anaesthesiologists physical status classification; GCS, Glasgow Coma Scale; COPD, chronic obstructive pulmonary disease; RBC, red blood cell.
Results of the multivariate analysis of factors associated with POP.
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
| Age (≥ 60 yr) | 0.483 | 0.244 | 3.940 | 0.047 | 1.622 | 1.006, 2.614 |
| COPD | 1.709 | 0.495 | 11.919 | 0.001 | 5.521 | 2.093, 14.565 |
| Emergency surgery | 1.226 | 0.423 | 8.401 | 0.004 | 3.407 | 1.487, 7.804 |
| Postoperative albumin (<35 g/L) | 0.800 | 0.220 | 13.281 | <0.001 | 2.226 | 1.447, 3.423 |
| Duration of ventilation (≥ 24 h) | 0.667 | 0.336 | 3.938 | 0.047 | 1.949 | 1.008, 3.766 |
| Duration of bed rest (≥ 3 days) | 0.983 | 0.232 | 17.892 | <0.001 | 2.671 | 1.694, 4.212 |
The outcomes of postoperative pneumonia.
|
|
|
| |
|---|---|---|---|
| The hospital stay (days) | 24.32 ± 14.64 | 16.16 ± 8.36 | <0.001 |
| ≥ 14 days | 202 (76.5%) | 154 (58.3%) | <0.001 |
| ≥ 30 days | 69 (26.1%) | 14 (5.3%) | <0.001 |
| ICU occupancy rate | 123 (46.6%) | 49 (18.6%) | <0.001 |
| Re-operation rate | 92 (34.8%) | 7 (2.7%) | <0.001 |
| Mortality rate | 8 (3.0%) | 0 (0%) | 0.004 |